Ben-Yedidia, T. Multimeric-001: BiondVax’s universal flu vaccine. Expert Rev. Vaccines 9(3), 241-241 (2010).
|
Christina M. Carlson, Elizabeth A. Turpin, Lindsey A. Moser, Kevin B. O'Brien, Troy D. Cline,3 Jeremy C. Jones, Terrence M. Tumpey, Jacqueline M. Katz, Laura A. Kelley, Jack Gauldie, Stacey Schultz-Cherry, Transforming Growth Factor-β: Activation by Neuraminidase and Role in Highly Pathogenic H5N1 Influenza Pathogenesis, PLoS Pathog. 2010 October; 6(10): e1001136. doi: 10.1371/journal.ppat.1001136
|
Dlugolenski D, Hauck R, Hogan RJ, Michel F, Mundt E. Development of a competitive ELISA for detection of H5 antibodies in multiple species. Avian Diseases, 54:644–649, 2010.
|
Jae-Min Song, Bao-Zhong Wang, Kyoung-Mi Park, Nico Van Rooijen, Fu-Shi Quan, Min-Chul Kim, Hyun-Tak Jin, Andrew Pekosz, Richard W. Compans, Sang-Moo Kang, Influenza Virus-Like Particles Containing M2 Induce Broadly Cross Protective Immunity, PLoS One. 2011; 6(1): e14538. doi: 10.1371/journal.pone.0014538
|
Jason T. Weinfurter, Kevin Brunner, Saverio V. Capuano, III, Chengjun Li, Karl W. Broman, Yoshihiro Kawaoka, and Thomas C. Friedrich, Cross-Reactive T Cells Are Involved in Rapid Clearance of 2009 Pandemic H1N1 Influenza Virus in Nonhuman Primates, PLoS Pathog. 2011 November; 7(11): e1002381, doi: 10.1371/journal.ppat.1002381
|
Jenny Aurielle B. Babon, John Cruz, Laura Orphin, Pamela Pazoles, Mary Dawn T. Co, Francis A. Ennis, Masanori Terajima, Genome-wide screening of human T-cell epitopes in influenza A virus reveals a broad spectrum of CD4+ T-cell responses to internal proteins, hemagglutinins, and neuraminidases, Human Immunology, Volume 70, Issue 9, September 2009, Pages 711-721, ISSN 0198-8859, 10.1016/j.humimm.2009.06.004.
|
Jesse D. Bloom, Jagannath S. Nayak, David Baltimore, A Computational-Experimental Approach Identifies Mutations That Enhance Surface Expression of an Oseltamivir-Resistant Influenza Neuraminidase, PLoS One. 2011; 6(7): e22201. doi: 10.1371/journal.pone.0022201
|
John W. Zinckgraf, Margaret Sposato, Veronica Zielinski, Doug Powell, John J. Treanor, Eric von Hofe, Identification of HLA class II H5N1 hemagglutinin epitopes following subvirion influenza A (H5N1) vaccination, Vaccine, Volume 27, Issue 39, 27 August 2009, Pages 5393-5401, ISSN 0264-410X, 10.1016/j.vaccine.2009.06.081.
|
Larry R. Smith, Mary K. Wloch, Ming Ye, Luane R. Reyes, Souphaphone Boutsaboualoy, Casey E. Dunne, Jennifer A. Chaplin, Denis Rusalov, Alain P. Rolland, Cindy L. Fisher, Mohamed S. Al-Ibrahim, Martin L. Kabongo, Roy Steigbigel, Robert B. Belshe, Ernest R. Kitt, Alice H. Chu, Ronald B. Moss, Phase 1 clinical trials of the safety and immunogenicity of adjuvanted plasmid DNA vaccines encoding influenza A virus H5 hemagglutinin, Vaccine, Volume 28, Issue 13, 16 March 2010, Pages 2565-2572, ISSN 0264-410X, 10.1016/j.vaccine.2010.01.029.
|
Libo Dong, Feng Liu, Jeffery Fairman, David K. Hong, David B. Lewis, Thomas Monath, John F. Warner, Jessica A. Belser, Jenish Patel, Kathy Hancock, Jacqueline M. Katz, Xiuhua Lu, Cationic liposome–DNA complexes (CLDC) adjuvant enhances the immunogenicity and cross-protective efficacy of a pre-pandemic influenza A H5N1 vaccine in mice, Vaccine, Available online 12 November 2011, ISSN 0264-410X, 10.1016/j.vaccine.2011.10.103.
|
M. Anthony Moody, Ruijun Zhang, Emmanuel B. Walter, Christopher W. Woods, Geoffrey S. Ginsburg, Micah T. McClain, Thomas N. Denny, Xi Chen, Supriya Munshaw, Dawn J. Marshall, John F. Whitesides, Mark S. Drinker, Joshua D. Amos, Thaddeus C. Gurley, Joshua A. Eudailey, Andrew Foulger, Katherine R. DeRosa, Robert Parks, R. Ryan Meyerhoff, Jae-Sung Yu, Daniel M. Kozink, Brice E. Barefoot, Elizabeth A. Ramsburg, Surender Khurana, Hana Golding, Nathan A. Vandergrift, S. Munir Alam, Georgia D. Tomaras, Thomas B. Kepler, Garnett Kelsoe, Hua-Xin Liao, and Barton F. Haynes, H3N2 Influenza Infection Elicits More Cross-Reactive and Less Clonally Expanded Anti-Hemagglutinin Antibodies Than Influenza Vaccination, PLoS One. 2011; 6(10): e25797, 2011 October 19. doi: 10.1371/journal.pone.0025797
|
Ramu A. Subbramanian, Saleem Basha, Mohamed T. Shata, Rebecca C. Brady, David I. Bernstein, Pandemic and seasonal H1N1 influenza hemagglutinin-specific T cell responses elicited by seasonal influenza vaccination, Vaccine, Volume 28, Issue 52, 6 December 2010, Pages 8258-8267, ISSN 0264-410X, 10.1016/j.vaccine.2010.10.077.
|
Roti M, Yang J, Berger D, Huston L, James EA, Kwok WW. Healthy human subjects have CD4+ T cells directed against H5N1 influenza virus. J Immunol. 2008 Feb 1;180(3):1758-68. PMID: 18209073 [PubMed - indexed for MEDLINE]
|
Saleem Basha, Staci Hazenfeld, Rebecca C. Brady, Ramu A. Subbramanian, Comparison of antibody and T-cell responses elicited by licensed inactivated- and live-attenuated influenza vaccines against H3N2 hemagglutinin, Human Immunology, Volume 72, Issue 6, June 2011, Pages 463-469, ISSN 0198-8859, 10.1016/j.humimm.2011.03.001.
|
Treanor JJ, Campbell JD, Zangwill KM, Rowe T, Wolff M. Evaluation of the Safety and Immunogenicity of an Inactivated Subvirion H5N1 Influenza Virus Vaccine in Humans. NEJOM. 2006; 354:1343-51.
|
Uhl E, Harvey SB, Michel F, Perozo Y, Tompkins SM, Hogan RJ. Immunogenicity of Avian H5N1 Influenza Virus Recombinant Vaccines in Cats. Viral Immunology, 23:221-226, 2010.
|
William A. Langley, Konrad C. Bradley, Zhu-Nan Li, Ganesh R. Talekar, Summer E. Galloway, David A. Steinhauer, The effects of preexisting immunity to influenza on responses to influenza vectors in mice, Vaccine, Volume 28, Issue 38, 31 August 2010, Pages 6305-6313, ISSN 0264-410X, 10.1016/j.vaccine.2010.06.112.
|
William C. Weldon, Bao-Zhong Wang, Maria P. Martin, Dimitrios G. Koutsonanos, Ioanna Skountzou, and Richard W. Compans, Enhanced Immunogenicity of Stabilized Trimeric Soluble Influenza Hemagglutinin, PLoS One. 2010; 5(9): e12466. doi: 10.1371/journal.pone.0012466
|
Yolanda D. Mahnke, Areej Saqr, Staci Hazenfeld, Rebecca C. Brady, Mario Roederer, Ramu A. Subbramanian, Age-related changes in durability and function of vaccine-elicited influenza-specific CD4+ T-cell responses, Vaccine, Volume 29, Issue 47, 3 November 2011, Pages 8606-8614, ISSN 0264-410X, 10.1016/j.vaccine.2011.09.019.
|
|